Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 14.90
+0.47 (3.26%)
Apr 24, 2026, 4:14 PM AEST
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
1.05M AUD
Profits / Employee
-9.27K AUD
Market Cap
5.05B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,184 | - | - | 1,120 | 64 |
| Mar 31, 2024 | 431 | 197 | 84.19% | 415 | 16 |
| Dec 31, 2022 | 234 | 76 | 48.10% | 234 | 0 |
| Dec 31, 2021 | 158 | - | - | 158 | 0 |
| Dec 31, 2017 | 9 | - | - | 9 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,904 |
| Clarity Pharmaceuticals | 88 |
| Mesoblast | 81 |
| Starpharma Holdings | 40 |
| Opthea | 33 |
Telix Pharmaceuticals News
- 4 days ago - ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026 - GlobeNewsWire
- 11 days ago - Telix Pharma Doses First Patient In Phase 3 IPAX BrIGHT Trial Of TLX101-Tx; Prices $600 Mln Bonds - Nasdaq
- 11 days ago - Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma - GlobeNewsWire
- 12 days ago - Fundies feast on Telix Pharmaceuticals block amid $US550m convertible - The Australian Financial Review
- 13 days ago - Telix Pharma Gains As Regeneron Tie-Up Targets Solid Tumor Programs - Benzinga
- 13 days ago - Regeneron (REGN) Partners with Telix Pharmaceuticals - GuruFocus
- 13 days ago - Regeneron (REGN) Partners with Telix Pharmaceuticals for Innovative Radiopharmaceuticals - GuruFocus
- 13 days ago - Regeneron Pharma Partners Telix Pharma To Jointly Develop Radiopharmaceutical Therapies - Nasdaq